arrow
S

Samandhy Cedeño

Hospital Universitari Germans Trias i Pujol
H指数:20
被引数:1,056

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Predictors of virological outcomes after analytical interruption of antiretroviral therapy and HTI vaccination in early treated people with HIV-1._

早期接受治疗的HIV-1感染者中,抗病毒治疗分析性中断和HTI疫苗接种后病毒学结局的预测因素。

2025-12-080
OAAI
Converging and evolving immuno-genomic routes toward immune escape in breast cancer
2024-02-213
OA
Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial

HTI疫苗在早期治疗的HIV-1感染中的安全性,免疫原性和对病毒反弹的影响: 一项随机,安慰剂对照的1期试验

2022-10-2733
OA
Limited Humoral and Specific T-Cell Responses After SARS-CoV-2 Vaccination in PWH With Poor Immune Reconstitution
2022-10-0624
OA
Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome

kick-and-kill治疗性疫苗BCN02临床试验中的表观遗传景观与抗逆转录病毒治疗中断 (ATI) 结果相关

2022-04-016
OAAI
Immune Profiles Identification by Vaccinomics After MVA Immunization in Randomized Clinical Study
2020-11-107
OAAI
HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02)

HIVconsv疫苗和Romidepsin在早期治疗的HIV-1-Infected个体: 安全性,免疫原性和对病毒库的影响 (研究BCN02)

2020-05-0664
OAAI
Direct Interrogation of Viral Peptides Presented by the Class I HLA of HIV-Infected T Cells

直接询问由HIV感染的T细胞的I类HLA呈递的病毒肽

2014-11-1543
OAAI